Sfoglia per Autore
Chronic lymphocytic leukemia: prognostic factors and stage classification (author's transl)
1979 Baccarani M.; Gobbi M.; Cavo M.; Tura S.
Assessmen of disease ativity in multiple myeloma with FDG-PET imaging
2004 Fanti S.; Yu JQ; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuangh H.M.; Cavo M.; FRanchi R.; Canini R.; Monetti N.; Alavi A.
New insights into the knowledge of graft-versus-myeloma
2004 M. Cavo
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
2004 Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Palareti G; Tura S; Baccarani M.
L'imaging del mieloma: la PET-TC nel follow-up del mieloma multiplo
2004 Fanti S.; Cavo M.; Moretti A.; Salizzoni E.; Battista G.; Canini R.
A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma.
2004 RIA R; VACCA A; RUSSO F; CIRULLI T; MASSAIA M; TOSI P; CAVO M.; GUIDOLIN D; RIBATTI D; DAMMACCO F.
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
2004 TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M.
Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma
2004 Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A.
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO).
2004 BAROSI G; BOCCADORO M; CAVO M.; CORRADINI P; MARCHETTI M; MASSAIA M; MERLINI G; TOSI P; TURA S; ITALIAN SOCIETY OF HEMATOLOGY; ITALIAN SOCIETY OF EXPERIMENTAL HEMATOLOGY; ITALIAN GROUP FOR BONE MARROW TRANSPLANTATION.
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
2005 CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERRAGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY.
Myeloma therapy: the future is bright
2005 Cavo M.
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
2005 TOSI P; ZAMAGNI E; CELLINI C; PLASMATI R; CANGINI D; TACCHETTI P; PERRONE; G; PASTORELLI F; TURA S; BACCARANI M.; CAVO M.
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants.
2005 GAHRTON G; IACOBELLI S; APPERLEY J; BANDINI G; BJORKSTRAND B; BLADE J; BOIRON JM; CAVO M.; CORNELISSEN J; CORRADINI P; KROGER N; LJUNGMAN P; MICHALLET M; RUSSELL NH; SAMSON D; SCHATTENBERG A; SIROHI B; VERDONCK LF; VOLIN L; ZANDER A; NIEDERWIESER D.
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
2006 Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M.
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treatedwith zoledronic acid and thalidomide-dexamethasone.
2006 Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'ArcoA; Ronconi S; Cellini C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S;Baccarani M; Cavo M.
Use of 18 FDG PET/CT to evaluate therapy response of bone myelomatous lesions
2006 C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Cavo; V. Allegri; C. Pettinato; G. Montini; S. Fanti.
Comparison between 18F-FDG PET/CT and 11C-Choline PET/CT for the evaluation of multiple myeloma
2006 C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Sansovini; D. Rubello; G. Montini; M. Cavo; S. Fanti.
Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion.
2006 Ambrosini V.; Farsad M.; Nanni C.; Schiavina R.; Rubello D.; Castellucci P.; Pasquini E.; Franchi R.; Cavo M.; Fanti S.
Role of (18)F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
2006 Nanni C.; Zamagni E.; Farsad M.; Castellucci P.; Tosi P.; Cangini D.; Salizzoni E.; Canini R.; Cavo M.; Fanti S.
The changing landscape of myeloma therapy.
2006 Cavo M; Baccarani M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Chronic lymphocytic leukemia: prognostic factors and stage classification (author's transl) | Baccarani M.; Gobbi M.; Cavo M.; Tura S. | 1979-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Assessmen of disease ativity in multiple myeloma with FDG-PET imaging | Fanti S.; Yu JQ; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuangh H.M.; ...Cavo M.; FRanchi R.; Canini R.; Monetti N.; Alavi A. | 2004-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 4.02 Riassunto (Abstract) | - |
| New insights into the knowledge of graft-versus-myeloma | M. Cavo | 2004-01-01 | BLOOD | - | 1.04 Replica / breve intervento (e simili) | - |
| First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma. | Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Pa...lareti G; Tura S; Baccarani M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| L'imaging del mieloma: la PET-TC nel follow-up del mieloma multiplo | Fanti S.; Cavo M.; Moretti A.; Salizzoni E.; Battista G.; Canini R. | 2004-01-01 | LA RADIOLOGIA MEDICA | - | 1.01 Articolo in rivista | - |
| A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma. | RIA R; VACCA A; RUSSO F; CIRULLI T; MASSAIA M; TOSI P; CAVO M.; GUIDOLIN D; RIBATTI D; DAMMACCO F. | 2004-01-01 | THROMBOSIS AND HAEMOSTASIS | - | 1.01 Articolo in rivista | - |
| Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure. | TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M. | 2004-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma | Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P....; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A. | 2004-01-01 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO). | BAROSI G; BOCCADORO M; CAVO M.; CORRADINI P; MARCHETTI M; MASSAIA M; MERLINI G; TOSI P; TURA S; I...TALIAN SOCIETY OF HEMATOLOGY; ITALIAN SOCIETY OF EXPERIMENTAL HEMATOLOGY; ITALIAN GROUP FOR BONE MARROW TRANSPLANTATION. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. | CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERR...AGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Myeloma therapy: the future is bright | Cavo M. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma. | TOSI P; ZAMAGNI E; CELLINI C; PLASMATI R; CANGINI D; TACCHETTI P; PERRONE; G; PASTORELLI F; TURA ...S; BACCARANI M.; CAVO M. | 2005-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. | GAHRTON G; IACOBELLI S; APPERLEY J; BANDINI G; BJORKSTRAND B; BLADE J; BOIRON JM; CAVO M.; CORNEL...ISSEN J; CORRADINI P; KROGER N; LJUNGMAN P; MICHALLET M; RUSSELL NH; SAMSON D; SCHATTENBERG A; SIROHI B; VERDONCK LF; VOLIN L; ZANDER A; NIEDERWIESER D. | 2005-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma. | Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; ...Tura S; Baccarani M; Cavo M. | 2006-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treatedwith zoledronic acid and thalidomide-dexamethasone. | Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'ArcoA; Ronconi S; Cellini... C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S;Baccarani M; Cavo M. | 2006-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Use of 18 FDG PET/CT to evaluate therapy response of bone myelomatous lesions | C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Cavo; V. Allegri; C. Pettinato;... G. Montini; S. Fanti. | 2006-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| Comparison between 18F-FDG PET/CT and 11C-Choline PET/CT for the evaluation of multiple myeloma | C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Sansovini; D. Rubello; G. Monti...ni; M. Cavo; S. Fanti. | 2006-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion. | Ambrosini V.; Farsad M.; Nanni C.; Schiavina R.; Rubello D.; Castellucci P.; Pasquini E.; Franchi... R.; Cavo M.; Fanti S. | 2006-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Role of (18)F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. | Nanni C.; Zamagni E.; Farsad M.; Castellucci P.; Tosi P.; Cangini D.; Salizzoni E.; Canini R.; Ca...vo M.; Fanti S. | 2006-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| The changing landscape of myeloma therapy. | Cavo M; Baccarani M. | 2006-01-01 | NEW ENGLAND JOURNAL OF MEDICINE | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile